Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Plus Therapeutics Inc (PSTV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cytori Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.750 +0.030    +1.74%
15/10 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US72941H4002 
CUSIP:  72941H400
  • Volume: 164,620
  • Bid/Ask: 1.740 / 1.770
  • Day's Range: 1.720 - 1.800
Cytori Therapeutics 1.750 +0.030 +1.74%
IndustryBiotechnology & Drugs
SectorHealthcare
Employees

12

Equity Type

ORD

Plus Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma. The Company also focuses on developing Rhenium-186 NanoLiposome (186RNL) for the treatment of recurrent glioblastoma-a rare, incurable and fatal disease.

Contact Information

Phone +1-858-4580900
Fax 302-6365454

Top Executives

Name Age Since Title
Richard J. Hawkins 72 2007 Independent Chairman of the Board
Robert P. Lenk 73 2020 Independent Director
Vladimir P. Torchilin - 2020 Member of Scientific Advisory Board
John C. McKew 57 2020 Member of Scientific Advisory Board
Andrew J. Brenner - 2020 Member of Scientific Advisory Board
Marc H. Hedrick 58 2002 President, CEO & Director
An van Es-Johansson 61 2020 Independent Director
Howard Clowes 67 2020 Independent Director
Michael Vogelbaum - 2020 Member of Clinical Advisory Board
Gregory B. Petersen 58 2020 Independent Director
Nicholas Butowski - 2020 Member of Clinical Advisory Board
Manish Aghi - 2020 Member of Clinical Advisory Board
Alireza Mohammadi - 2020 Member of Clinical Advisory Board
Russell Lonser - 2020 Member of Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PSTV Comments

Write your thoughts about Plus Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nash Purswani
Nash Purswani Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zero sales but everyone says strong buy - always confused with this Co but stuck n feels like slow quiksand
Pochette Million
Pochette Million Apr 15, 2020 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its a very strong buy
En Game
En Game Apr 15, 2020 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I guess its an even stronger buy today
victor cruz
victor cruz Nov 14, 2019 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its merging from the ashes now.
Scott Wallace
Scott Wallace Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Really what happened????
Sarika Ramonda
Sarika Ramonda Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$PSTV Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public OfferingThe Series U Warrants have an exercise price of $5.00 per share
Jack Wood
Jack Wood Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stupid firm offered millions of share mid-day at 5$ while stock was still trading at 10$. It just took few seconds to drop to 4$. It was unfair of them to do offering at 5$ as lots of bulls got trapped within seconds.
Roland Jambrich
Roland Jambrich Sep 23, 2019 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After 8 yesterday, first 16, then 3,56 today? What's going on here?
andrea ciotoli
andrea ciotoli Aug 22, 2019 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1:50
Nash Purswani
Nash Purswani Aug 16, 2019 11:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone holding the cytori warrants and know how it will be converted - same 50:1 ?
Kevin White
Kevin White Mar 14, 2018 5:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock has a strong buy technical analysis and it should. Has the potential of quadrupole gains. Bought at 0.33 and looking to make thousands off this when it hits over a 1.00.
Memet Awad
Memet Awad Mar 14, 2018 5:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you missed on this. reverse split in a couple of weeks
Nate Brown
Nate Brown Mar 14, 2018 5:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't think so.
Suwat Leerats
watneywatney2 Jan 06, 2018 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
8 year was 118 now is 0.4
Memet Awad
Memet Awad Jan 06, 2018 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
not true..they did two reverse splits
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email